Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

OptiNose, Inc.

OPTNNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$9.60
$0.00(0.00%)
U.S. Market is Open • 14:29

OptiNose, Inc. Fundamental Analysis

OptiNose, Inc. (OPTN) shows strong financial fundamentals with a PE ratio of -5.02, profit margin of -36.35%, and ROE of 46.86%. The company generates $0.1B in annual revenue with strong year-over-year growth of 10.20%.

Key Strengths

ROE46.86%
Cash Position65.11%

Areas of Concern

Operating Margin-15.13%
PEG Ratio2.63
Current Ratio0.64
We analyze OPTN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 44.5/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
44.5/100

We analyze OPTN's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPTN struggles to generate sufficient returns from assets.

ROA > 10%
-19.42%

Valuation Score

Moderate

OPTN shows balanced valuation metrics.

PE < 25
-5.02
PEG Ratio < 2
2.63

Growth Score

Moderate

OPTN shows steady but slowing expansion.

Revenue Growth > 5%
10.20%
EPS Growth > 10%
-5.63%

Financial Health Score

Moderate

OPTN shows balanced financial health with some risks.

Debt/Equity < 1
-2.07
Current Ratio > 1
0.64

Profitability Score

Weak

OPTN struggles to sustain strong margins.

ROE > 15%
46.86%
Net Margin ≥ 15%
-36.35%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPTN Expensive or Cheap?

P/E Ratio

OPTN trades at -5.02 times earnings. This suggests potential undervaluation.

-5.02

PEG Ratio

When adjusting for growth, OPTN's PEG of 2.63 indicates potential overvaluation.

2.63

Price to Book

The market values OptiNose, Inc. at -1.83 times its book value. This may indicate undervaluation.

-1.83

EV/EBITDA

Enterprise value stands at 15.05 times EBITDA. This signals the market has high growth expectations.

15.05

How Well Does OPTN Make Money?

Net Profit Margin

For every $100 in sales, OptiNose, Inc. keeps $-36.35 as profit after all expenses.

-36.35%

Operating Margin

Core operations generate -15.13 in profit for every $100 in revenue, before interest and taxes.

-15.13%

ROE

Management delivers $46.86 in profit for every $100 of shareholder equity.

46.86%

ROA

OptiNose, Inc. generates $-19.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

-19.42%

Following the Money - Real Cash Generation

Operating Cash Flow

OptiNose, Inc. generates limited operating cash flow of $-16.07M, signaling weaker underlying cash strength.

$-16.07M

Free Cash Flow

OptiNose, Inc. generates weak or negative free cash flow of $-16.09M, restricting financial flexibility.

$-16.09M

FCF Per Share

Each share generates $-1.59 in free cash annually.

$-1.59

FCF Yield

OPTN converts -19.06% of its market value into free cash.

-19.06%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.63

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.58

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.07

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.47

vs 25 benchmark

ROA

Return on assets percentage

-0.19

vs 25 benchmark

ROCE

Return on capital employed

0.15

vs 25 benchmark

How OPTN Stacks Against Its Sector Peers

MetricOPTN ValueSector AveragePerformance
P/E Ratio-5.0229.43 Better (Cheaper)
ROE46.86%800.00% Weak
Net Margin-36.35%-20145.00% (disorted) Weak
Debt/Equity-2.070.30 Strong (Low Leverage)
Current Ratio0.644.64 Weak Liquidity
ROA-19.42%-17936.00% (disorted) Weak

OPTN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews OptiNose, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

831.34%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

18.48%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-103.79%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ